中文
English
한국어
日本語
Español
Français
Русский
| 카탈로그 번호 | AF879054 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 응용 분야 | ELISA | ||||||||
| 숙주 종 | Rabbit | ||||||||
| 이소타입 | IgG | ||||||||
| 클론성 | Polyclonal | ||||||||
| 면역원 | Certolizumab | ||||||||
| 타겟 | Certolizumab | ||||||||
| 특이성 | The product is specific for Certolizumab. This antibody serves as an excellent positive control for Certolizumab immunogenicity (ADA) assays. | ||||||||
| 내독소 수준 | Please contact with the lab for this information. | ||||||||
| 정제 | Purified by antigen affinity column. | ||||||||
| 등록번호 | CAS: 428863-50-7 | ||||||||
| 형태 | Liquid | ||||||||
| 저장 완충액 | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. 데이터시트 인쇄본 또는 로트별 COA에 기재된 구체적인 완충액 정보를 참조하세요. |
||||||||
| 제품 사용 정보 |
| ||||||||
| 안정성 및 저장 | The product can be stored for 2 - 3 weeks at 2 to 8°C or for up to 12 months at -20°C. Avoid repeated freezing and thawing cycles. | ||||||||
| 배경 | Certolizumab is a Fab fragment of a monoclonal antibody to human tumor necrosis factor alpha (TNFα) which has potent antiinflammatory activity and is used in the therapy of severe rheumatoid arthritis and inflammatory bowel disease. Antibodysystem Anti-Certolizumab Antibody, pAb, Rabbit is produced from sera of a rabbit immunized with Certolizumab. • Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial., PMID:37423647 • Certolizumab Pegol: A Review in Moderate to Severe Plaque Psoriasis., PMID:32207094 • Certolizumab Pegol in Plaque Psoriasis: Considerations for Pregnancy., PMID:33769772 • Certolizumab treatment of localized pyoderma gangrenosum in a pregnant patient., PMID:37905433 • Certolizumab pegol for hidradenitis suppurativa: Case report and literature review., PMID:33135826 • Certolizumab pegol for induction of remission in Crohn's disease., PMID:31476018 • ACG Clinical Guideline: Management of Crohn's Disease in Adults., PMID:29610508 • [Certolizumab]., PMID:31208736 • Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation., PMID:27140438 • Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis., PMID:31917928 | ||||||||
| 참고사항 | For research use only. |
Western blot analysis was performed using anti-Certolizumab polyclonal antibody at 1ug/mL on recombinant Certolizumab (Catalog No. HF879016).
+86-027-65523339
중국 우한시 심둔사로 666번지 C동, 우한, 430206
